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Schizophrenia (SCZ) is a complex mental disorder with high
heritability and elusive genetic architecture. In the etiology of the
disease, an emphasis has been placed in the detection of multiple
common risk genes through whole genome sequencing (WGS).
Due to the overlap of clinical symptoms with several other
psychiatric disorders, a recognized goal is to provide more
objectivity and accuracy in diagnosing patients.
Recent studies implied that Carbohydrate Sulfotransferase 9
(CHST9) is associated with SCZ by its copy number variation
(CNV). CHST9 has also been linked to the development of breast
cancer, gastric cancer, and multiple hematologic malignancies.
Whole genome sequencing was conducted for 20 families, 9
frameshift mutations were identified in more than 2 families. A
frameshift deletion of CA (-/CA) was at chromosome 18:24722723
on the Carbohydrate Sulfotransferase 9 (CHST9) gene. We
observed this deletion in 4 affected persons of two families from
whole genome sequencing. All the deletion was confirmed by
polymerase chain reaction (PCR)-based Sanger Sequencing.

Dataset:
Whole genome sequencing for 99 subjects from 20 Chinese families.

Integrative Genome Viewer (IGV)

Whole Genome Sequencing
Table 2. Frameshift mutations from whole genome sequencing.

Family 35-13523

Family 35-02478

Study Design

Figure 1. Analysis for 01C0848 (-/CA).

Polymerase Chain Reaction (PCR)

Family-Based Study Design
Discovery Sample
●99 subjects from 20 Chinese families
Replication Sample
●85 subjects from another independent 17 Chinese families
Selection criteria:
●Minimum of 2 diagnosed siblings
●One unaffected sibling at the age of 32 or older
●Both parents are included if available
Advantages of our study design:
●Parent inclusion allows us to determine de novo mutations
●Inclusion of the sibling aids in excluding a majority of variants found in
the affected subject
●Allows us to use transmission to calculate odds ratio
Determination of Relatedness
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Figure 2. Examples of a single family pedigree.

Figure 3. Gel electrophoresis result for Family 35-13523.

PCR-Based Sanger Sequencing

Figure 4. CHST9 frameshift deletion of 01C08148.

Conclusion
CHST9 frameshift deletion is found in two families. All the deletion was confirmed by polymerase chain reaction (PCR)-based
Sanger Sequencing. Given the frequencies of this mutation observed in the general population (data from ExAC database:
http://exac.broadinstitute.org/) are between 0.00266 to 0.000207, the p-value that CHST9 associated with schizophrenia is
0.000207^2 to 0.00266^2, or 4.28E-08 to 7.0756E-06.
Table 1. Kinship selection matrix

